1 min read.Updated: 11 May 2022, 03:45 PM ISTLivemint
Sharing as its top pick for the month, the brokerage has buy rating on the pharma stock with a target price of ₹1,070
Listen to this article
Cipla shares have been under pressure since quiet some time but at this juncture its trading near its crucial support. Previously, the stock turned from this level and a rally towards ₹1,080 was seen, highlighted domestic brokerage and research firm Anand Rathi in a note.